Combination of old and new drugs to improve renal outcome in SLE patients
Author:
Affiliation:
1. Department of Autoimmune Diseases, Reference Centre (UEC/CSUR) for the Catalan and Spanish Health Systems, Member of ERN-ReCONNET, Hospital Clínic , Barcelona, Catalonia, Spain
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Link
https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/kead458/51608363/kead458.pdf
Reference11 articles.
1. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis;Fanouriakis;Ann Rheum Dis,2020
2. Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials;Gomez;Rheumatology,2023
3. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus;Fanouriakis;Ann Rheum Dis,2019
4. Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial;Sun;Lupus Sci Med,2022
5. Population pharmacokinetics of belimumab following intravenous administration in patients with systemic lupus erythematosus;Struemper;J Clin Pharmacol,2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3